Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Metagenomi, Inc. (“Metagenomi” or the “Company”) (NASDAQ: MGX).
https://mma.prnewswire.com/media/2395212/Glancy_Prongay.jpg
Class Period: February 2024 IPOLead Plaintiff Deadline: November 25, 2024
If you wish to serve as lead plaintiff of the Metagenomi lawsuit, you can submit your contact information at www.glancylaw.com/cases/Metagenomi-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.
The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investorsthat: (1) Metagenomi’s collaboration with Moderna would not extend into the future but instead terminate in the immediate future; and (2) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Follow us for updates on LinkedIn, Twitter, or Facebook.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish tolearn moreabout this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
ContactsGlancy Prongay & Murray LLP, Los AngelesCharles Linehan, 310-201-9150 or 888-773-9224shareholders@glancylaw.comwww.glancylaw.com
https://c212.net/c/img/favicon.png?sn=LA26667&sd=2024-10-15
View original content to download multimedia:https://www.prnewswire.com/news-releases/mgx-investors-have-opportunity-to-lead-metagenomi-inc-securities-fraud-lawsuit-302271173.html
SOURCE Glancy Prongay & Murray LLP
https://rt.newswire.ca/rt.gif?NewsItemId=LA26667&Transmission_Id=202410151200PR_NEWS_USPR_____LA26667&DateId=20241015
COMTEX_458825825/1005/2024-10-15T12:00:30